Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type Active Not Recruiting Phase 3 Trials for Carmustine (DB00262)

IndicationStatusPhase
DBCOND0121728 (Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02443077Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaTreatment